Zdrowie i gospodarka · 23/09/2019
FDA Releases Draft Guidance on Complex Innovative Clinical Trial Designs for Drugs and Biological Products
The FDA has published a draft guidance document outlining recommendations for interacting with the agency on complex innovative clinical trial design proposals for drugs and biological products, in line with the 21st Century Cures Act.
Source: Federal Register — Food and Drug AdministrationOpen original release →